Organigram Holdings Inc. - Common Shares (OQ:OGI)
Business Focus: N/A
Apr 08, 2024 06:00 am ET
Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has been recognized on the 2024 Report on Business ‘Women Lead Here’ list for gender diversity. Fifty percent of the Company’s executive leadership team, including its CEO, are women.
Apr 03, 2024 08:06 am ET
Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, celebrates a monumental achievement as its SHRED brand surpasses the $200 million mark in yearly retail sales.1
Apr 02, 2024 08:51 am ET
Organigram Successfully Closes Previously Announced Underwritten Public Offering
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI) announces today the closing of its previously announced underwritten public offering of units of the Company (the “Units”) for total gross proceeds of C$28,750,230 (the “Offering”). The Company sold 8,901,000 Units at a price of C$3.23 per Unit, which included 1,161,000 Units sold pursuant to the exercise in full of the Underwriters’ over-allotment option.
Mar 27, 2024 08:56 am ET
Organigram Announces Pricing of Overnight Marketed Public Offering
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today that, in connection with its previously announced overnight marketed public offering of units of the Company (the “Units”), it has entered into an underwriting agreement with ATB Securities Inc., as lead underwriter, on behalf of itself and a syndicate of underwriters to sell 7,740,000 Units at a price of C$3.23 per Unit (the “Offering Price”) for total gross proceeds of approximately C$25 million (the “Offering”).
Mar 26, 2024 07:06 pm ET
Organigram Announces Launch of Overnight Marketed Public Offering
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today an overnight marketed public offering of units of the Company (the “Units”) for total gross proceeds of approximately C$25 million (the “Offering”). The Offering is expected to be completed pursuant to an underwriting agreement to be entered into between the Company and ATB Securities Inc., as lead underwriter, on behalf of itself and a syndicate of underwriters including A.G.P. Canada Investments ULC. The Offering will be made in the United States through the lead underwriter's U.S. affiliate, AT
Mar 26, 2024 01:36 pm ET
Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) is pleased to announce a US $2 million minority investment in Steady State LLC (d/b/a Open Book Extracts) (“OBX”) in the form of a convertible note.
Mar 22, 2024 07:00 pm ET
Organigram Receives Health Canada’s Final Redetermination on Jolts
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced today that, despite strong evidence supporting its classification as an ingestible extract, it has received a final redetermination from Health Canada that its patented Edison Jolts lozenge products (the “Products”) are to be classified as edible cannabis.
Feb 28, 2024 08:00 am ET
Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) enthusiastically supports the Standing Committee on Finance’s recent recommendation on the Excise Duty framework.
Feb 13, 2024 06:00 am ET
Organigram Reports First Quarter Fiscal 2024 Results
“We certainly kicked off fiscal 2024 with a bang", said Beena Goldenberg, Chief Executive Officer. “By closing the first tranche of our $124.6 million follow-on investment from BAT shortly after quarter end, we have removed a significant amount of risk from our business while enhancing the key competitive advantages that our team worked diligently to put into place in Fiscal 2023. We can now fully leverage our world-class facilities, market leadership in several categories, and cutting-edge research and development capabilities to increase Organigram's reach both within the Canadian market and
Feb 07, 2024 06:00 am ET
Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2024 ended December 31, 2023, on Tuesday, February 13, 2024, prior to market open.
Jan 31, 2024 06:00 am ET
Organigram Completes First Shipment to Germany, Extending its International Reach
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis today announced that it has sent its first shipment of bulk dried flower to the medical division of German cannabis company, Sanity Group, a health and sciences organization dedicated to the medical applications of cannabinoids. Organigram is pleased to complete its first shipment to Germany, one of the world’s largest and growing medical markets, as part of its multi-year agreement with Sanity Group.
Jan 24, 2024 06:00 am ET
Organigram Announces the First Tranche Closing from BAT Investment
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has closed the first of three tranches of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. (the “Investor”), a wholly owned subsidiary of British American Tobacco plc (“BAT”). Pursuant to the first tranche closing, the Investor acquired 12,893,175 common shares of the Company at a price of C$3.2203 per share (the “Per Share Price”) fo
Jan 19, 2024 06:00 am ET
Organigram Announces Appointment of Karina Gehring to Board of Directors
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), announced the appointment of Karina Gehring to the Organigram Board of Directors at the Company’s annual general and special meeting held on January 18, 2024.
Jan 18, 2024 08:00 pm ET
Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Shareholders”) held virtually on January 18, 2024 (the “Meeting”).
Dec 29, 2023 06:00 am ET
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the “Circular”) and related materials (the “Meeting Materials”) for its annual and special meeting (the “Meeting”) of the holders of its common shares (the “Shareholders”) to be held on January 18, 2024. In addition to routine annual business to be conducted (including the election of directors and the appointment of an auditor), Shareholders at the M
Dec 19, 2023 06:00 am ET
Organigram Reports Fiscal 2023 Results1
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the fourth quarter and thirteen months ended September 30, 2023 (“Q4 Fiscal 2023” or "Fiscal 2023").
Dec 18, 2023 06:00 am ET
Organigram Announces Appointment of Greg Guyatt as Chief Financial Officer
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) is pleased to announce that Greg Guyatt CPA, CA, formerly of Phoena Holdings Inc. (“Phoena”), has been appointed to the role of Chief Financial Officer effective January 8, 2024. Mr. Guyatt will lead Organigram’s Finance and IT divisions and will report directly to Beena Goldenberg, Organigram’s Chief Executive Officer.
Dec 14, 2023 06:00 am ET
Organigram to Report Fourth Quarter and Fiscal 2023 Results on December 19, 2023
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2023 ended September 30, 2023, on Tuesday, December 19, 2023, before market open.
Dec 13, 2023 06:00 am ET
Organigram Wins KIND Magazine’s Innovation of the Year for SHRED X Rip-Strips Hash
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabis (the “Company” or “Organigram”), is thrilled to announce it has won KIND Magazine’s (“KIND”) Innovation of the Year award for its revolutionary SHRED X Rip-Strips Hash. This is the second time Organigram has won this coveted award, having previously won for the Company’s patented Edison JOLTS ingestible extract product.
Nov 28, 2023 06:00 am ET
Organigram Increases Investment in Phylos After Successful Milestone Achievement
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that Phylos Bioscience Inc. (“Phylos”), a U.S. cannabis genetics company and provider of production ready seeds, has achieved the first milestone under the loan agreement entered into in May 2023 (the “Loan Agreement”) and has closed the second tranche under the Loan Agreement with Organigram advancing US$2.75 million to Phylos. This second tranche follows the initial tranche of US$3.25 million advanced in May 2023 for a total of US$6 million in senior se
Nov 10, 2023 06:00 am ET
Organigram Announces Interim Chief Financial Officer
The Board of Directors (the “Board”) of Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) today announced that Derrick West has informed Organigram that he will transition away from his role as Chief Financial Officer (“CFO”) in order to take time to focus on his health and recovery following surgery later this month.
Nov 07, 2023 08:31 am ET
Thinking about buying stock in Cybin Inc, Marinus Pharmaceuticals, Cardio Diagnostics, OrganiGram Holdings, or Pharming Group?
NEW YORK, Nov. 7, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CYBN, MRNS, CDIO, OGI, and PHAR.
Nov 06, 2023 06:00 am ET
Organigram Announces C$124.6 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce a C$124.6 million follow-on strategic equity investment from BT DE Investments Inc., (the “Investment”), a wholly-owned subsidiary of BAT (LSE: BATS and NYSE: BTI) (“BAT”), a leading, multi-category consumer goods business with a purpose to build A Better Tomorrow.™
Oct 18, 2023 06:00 am ET
Organigram Provides Corporate Update
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to provide a corporate update.
Oct 11, 2023 08:00 pm ET
Organigram Holdings Inc. Files Final Base Shelf Prospectus
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licenced producer of cannabis, announced today that it has obtained a receipt for a final short form base shelf prospectus (the “Base Shelf Prospectus”) filed with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10 (the “Registration Statement”) has been filed with the United States Securities and Exchange Commission (SEC File No. 333-274686) but is not yet effective.
Sep 25, 2023 08:00 pm ET
Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licenced producer of cannabis, announced today that it has filed a preliminary short form base shelf prospectus (the “Base Shelf Prospectus”) with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10 (the “Registration Statement”) has been filed with the United States Securities and Exchange Commission but is not yet effective.
Sep 01, 2023 06:00 pm ET
Organigram Announces Resignation of Board Member
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announces today that Ms. Caroline Ferland has resigned from the Board of Directors (“the Board”) effective immediately. Ms. Ferland was a board member nominee appointed by BAT.
Aug 28, 2023 06:00 am ET
Organigram Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to launch its first range of whole-flower derived THCV products through the Company’s popular SHRED and newly re-launched Trailblazer brands.
Aug 21, 2023 06:00 am ET
Organigram Relaunches one of Canada’s First Cannabis Brands, Trailblazer
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the relaunch of one of Canada’s best known cannabis brands, Trailblazer, exemplifying the Company’s commitment to keeping consumer insights at the heart of its brand and product development strategy. More than a year in the making, Trailblazer’s modernized brand identity and revitalized product lineup represent a significant opportunity to connect with a large and important consumer segment whose needs were previously unmet by the Organigram brand
Aug 15, 2023 08:52 am ET
Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce today that it has expanded its global footprint by entering into a supply agreement (“the Agreement”) to provide dried Medical Cannabis flower to 4C LABS, a rapidly scaling healthcare, technology, and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution, and clinical development of cannabis-based products for human health in the United Kingdom.
Aug 10, 2023 08:00 am ET
Organigram’s Application for Judicial Review on Jolts Ingestible Extract Granted
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced today that the Federal Court of Canada (the “Court”) has granted Organigram’s application for judicial review of a decision of Health Canada determining that the Edison Jolts lozenges (the “Products”) are to be classified as edible cannabis. The Court found there was a breach of procedural fairness by Health Canada. The matter is being remitted back to Health Canada for redetermination taking the Court’s reasons into consideration.
Aug 02, 2023 06:00 am ET
Organigram Launches New Tube-style Pre-rolls: SHRED Dartz and Holy Smokes
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of its new tube-style pre-rolls, SHRED Dartz and Holy Smokes. These tube-style pre-rolls mark the inception of 0.4g pre-rolls for Organigram, crafted using the state-of-the-art, high-speed Cantos tube-style rolling machine, complemented by cutting-edge packaging capabilities. Organigram today, is one of a small number of licensed producers (LPs) in Canada that possess the equipment and expertise to manufacture this sophisticated tube-sty
Jul 07, 2023 08:00 pm ET
Organigram to Report Third Quarter Fiscal 2023 Results on July 13, 2023
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter fiscal 2023 ended May 31, 2023, on Thursday, July 13, 2023, after market close.
Jul 05, 2023 02:30 pm ET
Organigram Announces Completion of Share Consolidation
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI) announced today that, further to its earlier press releases, it has completed the proposed consolidation of the Company’s issued and outstanding common shares at a...
Jun 21, 2023 10:00 am ET
Organigram Introduces Ultra High-THC Infused Pre-Rolls, SHRED X Heavies
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of SHRED X Heavies, a line of innovative infused pre-rolls. Infused with both diamonds and distillate, this is the first infused pre-roll offering from Organigram that will have a potency of over 40%. The infusion of botanical terpenes further enhances the natural terpene profiles of the blends, taking them to new and delicious heights.
Jun 19, 2023 08:00 pm ET
Organigram Announces Effective Date of Share Consolidation
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI) announced today that its Board has approved the consolidation of the Company’s issued and outstanding common shares at a consolidation ratio of four (4) pre-consolidation common shares for every post-consolidation common share (the “Share Consolidation”). The Share Consolidation is being implemented to ensure the Company continues to comply with Nasdaq listing requirements, reduce volatility and to enhance the marketability of the common shares to institutional investors.
May 25, 2023 02:09 pm ET
Organigram Makes First Strategic U.S. Investment in Phylos Bioscience to Commercialize THCV and Scale Seed Based Production
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that it has reached agreement with Phylos Bioscience Inc. (“Phylos”), a U.S. cannabis genetics company and provider of production ready seeds, based in Portland, Oregon, to initiate a wide-ranging technical and commercial relationship in Canada. This innovation relationship is expected to further support Organigram’s industry leading cultivation efforts in Canada with patent-pending foundational technologies and genetics. In the future, subject to receipt
May 23, 2023 06:00 am ET
Organigram to Enter German Market Supplying Sanity Group
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce today that it has entered into a supply agreement (“the Agreement”) for dried flower with the medical division of German cannabis company Sanity Group, a health and life sciences company based in Berlin, Germany, dedicated to the medical applications of cannabinoids. Through exports from its flagship state-of-the-art cultivation facility in Moncton, Organigram already services medical patients in Israel and Australia, and will now add Germany to it
May 19, 2023 08:00 pm ET
Organigram Announces Achievement of Earnout by The Edibles and Infusions Corporation
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that its wholly-owned subsidiary, The Edibles and Infusions Corporation (“EIC”) has met certain of the remaining earnout milestones that formed part of the terms of its acquisition in April, 2021.
Apr 11, 2023 07:00 pm ET
Organigram Reports Second Quarter Fiscal 2023 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2023 (“Q2 Fiscal 2023”). All financial information in this press release is expressed in thousands of Canadian dollars ("$"), except for references to $ millions.
Apr 04, 2023 06:00 am ET
Organigram to Report Second Quarter Fiscal 2023 Results on April 11, 2023
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2023 ended February 28, 2023, on Tuesday, April 11, 2023, after market close.
Mar 31, 2023 06:00 am ET
Organigram Accelerates Focus on Vapes With Strategic Investment in Greentank
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it has entered into a product purchase agreement (“Purchase Agreement”) with Green Tank Technologies Corp. (“Greentank”) a leading vaporization technology company and a subscription agreement (“Subscription Agreement”) with Greentank’s parent company, Weekend Holdings Corp (“Holdings”).
Mar 21, 2023 06:00 am ET
Organigram Announces Director Appointment
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced that BAT has designated Ms. Caroline Ferland as a nominee to Organigram’s board of directors (the “Board”). Caroline Ferland is a lawyer with extensive international experience assisting multinational companies to operate with confidence and integrity in highly regulated and high-risk environments. As the first Group Head of Business Conduct and Compliance for BAT, Caroline led the design and implementation of BAT’s global compliance and ethics programme (BAT operates in more than 150 jurisdictions acro
Mar 13, 2023 06:00 am ET
Organigram Provides Edison JOLTS Product Update
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced that it has received notification from Health Canada that Health Canada has determined that certain Jolts lozenge products in their 100 mg THC per package format (the “Products”) have been improperly classified as an “extract” rather than an “edible” under the Cannabis Regulations. The Company launched the Products in August 2021 following significant research, development and regulatory work. The Company remains of the view that the patent pending Products are properly classified as cannabis extracts a
Feb 28, 2023 08:00 pm ET
Organigram Holdings Inc. Announces Election of Directors
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders held on February 28, 2023 (the “Meeting”).
Feb 27, 2023 06:00 am ET
Organigram Revolutionizes Hash with SHRED X Rip-Strip Hash
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of SHRED X Rip-Strip Hash, a first-of-its-kind innovation in the Canadian cannabis industry. This botanical terpene-infused hash is unlike any other on the market – with 10 pre-cut strips of hash available in a 2g format. This product is a new ultra-convenient hash offering from SHRED that is available in the legendary Tropic Thunder and new Blueberry Blaster flavour profiles.
Jan 26, 2023 06:00 am ET
Organigram Provides NASDAQ Listing Update
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), today announced that it received notification (the “Notification”) from The Nasdaq Stock Market LLC (“NASDAQ”) that it is not in compliance with the minimum bid price requirement in NASDAQ Listing Rule 5450(a)(1) for continued listing on the NASDAQ Global Select Market, since the closing bid price for the Company’s common shares listed on NASDAQ was below US$1.00 for 30 consecutive trading days. NASDAQ Listing Rule 5450(a)(1) requires the common shares to maintain a minimum bid price of US$1.00 per share (the “Mi
Jan 12, 2023 06:00 am ET
Organigram Reports Record First Quarter Fiscal 2023 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2022 (“Q1 Fiscal 2023”). All financial information in this press release is expressed in thousands of Canadian dollars ("$"), except for references to $ millions.
Jan 05, 2023 06:00 am ET
Organigram to Report First Quarter Fiscal 2023 Results on January 12, 2023
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2023 ended November 30, 2022, on Thursday, January 12, 2023, before market open.
Dec 08, 2022 06:00 am ET
Organigram Wins KIND Magazine’s Cannabis Company of the Year Award and Most Innovative Product of the Year for Edison JOLTS
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabis (the “Company” or “Organigram”), is pleased to announce it has won KIND Magazine’s (“KIND”) Cannabis Company of the Year award. Considered KIND’s marquee award, Cannabis Company of the Year is presented to the licensed producer that the KIND editorial team believes demonstrates the best combination of people, purpose and product in a given year.
Nov 28, 2022 08:00 pm ET
Organigram Reports Record Fourth Quarter and Full Year Fiscal 2022 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the fourth quarter and year ended August 31, 2022 (“Q4 Fiscal 2022” or "Fiscal 2022").
Nov 23, 2022 06:00 am ET
Organigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash Categories
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of HOLY MOUNTAIN, the Company’s newest value brand featuring an initial lineup of dried flower strains and entering the market with value pressed hash. With the introduction of HOLY MOUNTAIN, Organigram will now offer value-priced flower in an expanded range of sizes, starting with 3.5g offerings at launch and additional sized formats expected soon after.
Nov 22, 2022 05:00 am ET
High Tide Becomes Top Revenue-Generating Cannabis Company in Canada
Data recently released by New Cannabis Ventures shows that the Company is now the largest revenue-generating company reporting in Canadian dollars.
Nov 22, 2022 05:00 am ET
High Tide Becomes Top Revenue-Generating Cannabis Company in Canada
Data recently released by New Cannabis Ventures shows that the Company is now the largest revenue-generating company reporting in Canadian dollars.
Nov 17, 2022 08:00 pm ET
Organigram to Report Annual Fiscal 2022 Results on November 28, 2022
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its annual and fourth quarter fiscal 2022 ended August 31, 2022 on Monday, November 28, 2022, after market close.
Nov 17, 2022 08:17 am ET
Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”), a leading Canadian licensed producer of cannabis, and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) Israel’s...
Nov 17, 2022 08:00 am ET
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”) a leading Canadian licensed producer of cannabis and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) Israel’s largest and most established pharmaceutical cannabis producer, today jointly announced that they have entered into a new multi-year agreement (the “New Strategic Agreement”) for Organigram to continue supply of dried flower to InterCure.
Jul 14, 2022 06:00 am ET
Organigram Reports Third Quarter Fiscal 2022 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the third quarter ended May 31, 2022 (“Q3 Fiscal 2022”).
Jul 08, 2022 08:00 pm ET
Organigram to Report Third Quarter 2022 Results on July 14, 2022
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter 2022 ended May 31, 2022 on Thursday, July 14, 2022 before market open.
Jun 23, 2022 08:00 pm ET
Proposed Settlement Reached in 2016 Class Action
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), and its subsidiary Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis in Canada, has reached a proposed settlement (“Settlement”) in a previously disclosed class action related to medical cannabis that was voluntarily recalled in December 2016 and January 2017 (“Class Action”). The Supreme Court of Nova Scotia (the “Court”) approved notice of Settlement will be sent to class members beginning on June 24, 2022.
Apr 12, 2022 06:00 am ET
Organigram Reports Second Quarter Fiscal 2022 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2022 (“Q2 Fiscal 2022”).
Apr 01, 2022 06:00 am ET
Organigram to Report Second Quarter 2022 Results on April 12, 2022
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter 2022 ended February 28, 2022 on Tuesday, April 12, 2022 before market open.
Mar 24, 2022 06:00 pm ET
Organigram Provides Corporate Update and Announces New Product Launches
Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (collectively “Organigram” or the “Company”), a leading licensed producer of cannabis, provided a corporate update today.
Mar 17, 2022 06:00 am ET
Organigram Joins the Pledge 1% Movement
Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (collectively “Organigram” or the “Company”), a leading licensed producer of cannabis, is pleased to announce the launch of its social impact strategy ‘Organigram Operating for Good’ with the purpose of ‘Building healthy communities where we live and work.’ As part of this strategy the Company has committed to giving back by joining the Pledge 1% Movement. Organigram has pledged ‘1% of Time’ which means the Company will be donating 1% of its employees’ time to local volunteer programs. Orga
Feb 28, 2022 06:23 pm ET
BAT Exercises Top-Up Rights to Invest $6.3 Million Resulting in an Increase in Equity Position from 18.8% to 19.5%
Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (collectively “Organigram” or the “Company”), a leading licensed producer of cannabis, is pleased to announce that BAT has invested an additional C$6.3 million into Organigram to enhance its equity ownership position in Organigram from 18.8% to 19.5% as of December 31, 2021 by exercising its rights pursuant to an investor rights agreement (the “Investor Rights Agreement”). The Investor Rights Agreement was entered into between Organigram and BAT in connection with the formation of the Product Development
Feb 23, 2022 07:30 pm ET
Organigram Holdings Inc. Announces Election of Directors
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual meeting of shareholders held on February 23, 2022 (the “Meeting”).
Jan 11, 2022 06:00 am ET
Organigram Reports First Quarter Fiscal 2022 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2021 (“Q1 Fiscal 2022”).
Jan 05, 2022 06:00 am ET
Organigram to Report First Quarter Fiscal 2022 Results on January 11, 2022
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2022 ended November 30, 2021 on Tuesday, January 11, 2022 before market open.
Dec 22, 2021 08:14 am ET
Organigram Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid Biosynthesis Company
As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI), (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, and Hyasynth Biologicals Inc. (“Hyasynth”) a private biotechnology company and pioneer in the field of cannabinoid science and biosynthesis are pleased to announce that Organigram has acquired an additional $2.5 million of secured convertible debentures in Hyasynth (the “Debentures”). Additionally, the parties have amended certain of the Debentures’ terms purchased by Organigram from Hyasynth in
Dec 21, 2021 08:33 am ET
Organigram Acquires Quebec-Based Laurentian Organic Inc. in Accretive Transaction
Laurentian was co-founded by Eric Brosseau, Mathieu Lahaie and Eric Verdier, a trio of highly passionate Quebecers who parlayed their love of cannabis into a successful cannabis company operating near the iconic Mont-Tremblant, specializing in high-quality, artisanal craft cannabis and premium Afghan hash. Organigram is excited to have a foothold in the Quebec market and is committed to building on the great progress made by the team at Laurentian through further investment in people and facilities in the province. The Company also plans to leverage its strong internal field sales force and na
Nov 23, 2021 06:00 am ET
Organigram Reports Fourth Quarter Fiscal 2021 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the fourth quarter ended August 31, 2021 (“Q4 Fiscal 2021”).
Nov 18, 2021 06:00 am ET
Organigram Launches New Wellness Brand, Monjour
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce the launch of Monjour, the Company’s new wellness brand, offering high-quality, CBD-forward products for consumers seeking easy and convenient ways to incorporate cannabidiol (CBD) into their daily wellness routine. Monjour’s first offerings in this emerging category include both vegan-friendly as well as sugar-free soft chews, both in assorted flavours.
Nov 15, 2021 06:00 am ET
Organigram to Report Fourth Quarter and Full Year Fiscal 2021 Results on November 23, 2021
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and full year fiscal 2021 ended August 31, 2021 on Tuesday, November 23, 2021 before market open.
Nov 01, 2021 06:00 am ET
Organigram Provides Corporate Update
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) (the “Company” or “Organigram”), the parent company of Organigram Inc., a leading licensed producer of cannabis, provided a corporate update today.
Aug 31, 2021 05:10 pm ET
Organigram Holdings Inc. Files Final Base Shelf Prospectus
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced today that it has obtained a receipt for a final short form base shelf prospectus (the “Base Shelf Prospectus”) filed with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10 (the “Registration Statement”) has been filed with the United States Securities and Exchange Commission (SEC File No. 333-257363), but is not yet effective.
Aug 25, 2021 06:00 am ET
Organigram Extends Popular SHRED Product Portfolio with High-quality, Value-priced SHRED’ems Gummies
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce the launch of SHRED’ems, a high-quality and bold flavoured lineup of cannabis-infused gummies. SHRED’ems is an extension of the Company’s highly popular, value-priced SHRED product portfolio which includes SHRED milled flower and SHRED Jar of Joints. Since launch in early August, SHRED’ems has already demonstrated great momentum, capturing the leading market share position of t
Aug 17, 2021 06:00 am ET
Organigram Launches Edison JOLTS, Reinvents the Ingestible Extract
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce the launch of Edison Cannabis Co. (“Edison”) JOLTS, Canada’s first flavoured high potency THC lozenge. Edison JOLTS are available in a package of 10 mint flavoured lozenges with 10 mg of THC per lozenge for a total of 100mg per pack.
Aug 04, 2021 06:00 am ET
Organigram Appoints Beena Goldenberg as Chief Executive Officer
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce Beena Goldenberg, formerly Chief Executive Officer of The Supreme Cannabis Company Inc. and previously Chief Executive Officer at Hain-Celestial Canada, ULC, has been appointed the Company’s new Chief Executive Officer (CEO). Ms. Goldenberg will assume the role effective September 9, 2021.
Jul 15, 2021 06:00 am ET
Organigram Launches Cannabis Innovators Panel
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of the Cannabis Innovators Panel, a cannabis consumer panel offering real-time insights into consumer preferences, usage occasions, and future development opportunities. This online panel will engage with 2,500 participants across Canada on an ongoing basis.
Jul 13, 2021 08:30 am ET
Thinking about buying stock in Cemtrex, Millendo Therapeutics, Exela Technologies, OrganiGram, or electroCore?
NEW YORK, July 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CETX, TPST, XELA, OGI, and ECOR.
Jul 13, 2021 06:00 am ET
Organigram Reports Third Quarter Fiscal 2021 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the third quarter ended May 31, 2021 (“Q3 2021”).
Jul 05, 2021 06:00 am ET
Organigram to Report Third Quarter Fiscal 2021 Results on July 13, 2021
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter Fiscal 2021 ended May 31, 2021 on Tuesday July 13, 2021 before market open.
Jun 24, 2021 05:09 pm ET
Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus
MONCTON, NB, June 24, 2021 /CNW/ - Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today that it has a filed a preliminary short form base shelf prospectus (the "Base Shelf Prospectus") with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10 (the "Registration Statement") has been filed with the United States Securities and Exchange Commission but is not yet effective.
Jun 03, 2021 06:42 pm ET
Organigram Recruits for as Many as 75 Roles Based in Moncton, New Brunswick
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce that it is currently recruiting for as many as 75 positions, across most functional areas of the Company. Positions include those in Operations, Production, Sanitation, Cultivation, Sales, Marketing, Research, and Quality Assurance.
May 31, 2021 06:00 am ET
Organigram Appoints Senior Vice President of Marketing
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the appointment of Megan McCrae as the Company’s Senior Vice President of Marketing and Communications. Ms. McCrae will assume her new role effective today.
May 18, 2021 06:00 am ET
Organigram Launches Big Bag o’ Buds Indoor-grown, Strain-specific Dried Flower in 28g Value Format
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, is pleased to announce the launch of Big Bag o’ Buds, a lineup of dried flower products featuring a roster of well-known genetics and an exciting rotation of one-time offerings (OTO) in a 28g format.
May 10, 2021 06:00 am ET
Organigram Appoints Vice President of Innovation
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the appointment of Borna Zlamalik as the Company’s Vice President of Innovation. Mr. Zlamalik will assume his new role effective today.
May 03, 2021 06:00 am ET
Organigram CEO Steps Away From Role, Will Continue to Act as a Special Advisor to the Board of Directors; Interim Leadership Appointed
The Board of Directors (the “Board”) of Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) has confirmed that Greg Engel is stepping away from his role as CEO effective today, however he will continue to act as a special advisor to the Board through a transition period. The Board is grateful for the contributions Greg has made since joining the Company in 2017.
Apr 22, 2021 01:30 pm ET
Organigram Expands Edison Cannabis Co. Dried Flower Portfolio with Two New High THC Strains: GMO Cookies and MAC-1
As part of the continued expansion of its Edison Cannabis Co. (“Edison”) line of products, Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of two new Edison dried flower strains including the potent GMO Cookies and legendary citrus diesel MAC-1.
Apr 13, 2021 06:00 am ET
Organigram Reports Second Quarter Fiscal 2021 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2021 (“Q2 2021”).
Apr 06, 2021 06:00 am ET
AgraFlora and Other Owners Agree to Sell Edibles Business for $35 Million to Organigram
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that it and its fellow shareholders have entered into an agreement to sell The Edibles & Infusions Corporation...
Apr 06, 2021 06:00 am ET
Organigram Acquires Soft Chew Manufacturer: Edibles & Infusions Corporation, a Cannabis Processor Backed by Decades of Confectionary Experience
Organigram Holdings Inc. (“OGI”, TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (together with OGI, “Organigram” or the “Company”), a leading producer of cannabis, is pleased to announce it has acquired all of the issued and outstanding shares of The Edibles & Infusions Corporation (“EIC”) (the “EIC Acquisition”) for consideration of $22.0 million, plus up to an additional $13.0 million in shares (the “Milestone Consideration”) payable upon the EIC business achieving certain earnout milestones (the “Milestones”). The EIC Acquisition further broadens Organigram’s continuum of
Apr 05, 2021 08:00 pm ET
Organigram to Report Second Quarter Fiscal 2021 Results on April 13, 2021
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter Fiscal 2021 ended February 28, 2021 on Tuesday April 13, 2021 before market open.
Apr 01, 2021 09:00 pm ET
Organigram Repays Credit Facilities with Bank of Montreal
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (collectively, the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company has repaid all outstanding balances (approximately $58.5 million) (the “Repayment”) under the facilities provided under its credit agreement (the “Credit Agreement”) dated November 27, 2020, with Bank of Montreal (“BMO”) as lead arranger and agent as well as a syndicate of other lenders.
Mar 30, 2021 06:00 am ET
Organigram Launches “Indi”, an Indica-only Brand, and Three New Edison Indica Pre-rolls: Black Cherry Punch, Ice Cream Cake (I.C.C.) and Slurricane
Building on the Company’s ongoing genetic exploration and product development program, Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of two new recreational product offerings:
Mar 11, 2021 03:21 pm ET
Wolf Haldenstein Adler Freeman & Herz LLP Is Investigating Organigram Holdings, Inc.
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of shareholders who sold their Organigram Holdings, Inc. (NASDAQ: OGI) shares on Wednesday, March 10, 2021 after hearing the news that BMO...
Mar 11, 2021 06:00 am ET
Organigram and BAT Form Product Development Collaboration – Includes Strategic Investment from BAT for 19.9% Equity Interest
Organigram Holdings Inc. (“OGI”, TSX: OGI and NASDAQ: OGI) is pleased to announce a C$221 million strategic investment from a wholly-owned subsidiary of BAT (LSE:BATS and NYSE:BTI). The BAT subsidiary has subscribed for approximately 58.3 million common shares of OGI, which represents a 19.9% equity interest1 on a post-transaction basis for total proceeds of approximately C$221 million (“Investment Proceeds”) at a price per share of C$3.792, based on a five-day volume weighted average price on the TSX ending March 9, 2021.
Mar 02, 2021 06:00 am ET
Organigram Launches SHRED Tropic Thunder Jar of J’s (Jar of Joints) and Trailblazer SNAX Milk Chocolate Bars
As part of its consumer-first product innovation strategy, Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of two new additions to the Company’s recreational cannabis product portfolio: SHRED Tropic Thunder Jar of Joints and Trailblazer SNAX Milk Chocolate Bars.
Mar 01, 2021 09:09 am ET
Cannabis and Psychedelics are Booming: CEO’s of Sundial Growers, Icanic Brands, OrganiGram, and Delic Holdings Are Ready
Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: OrganiGram Holdings (NASDAQ: OGI) Icanic Brands (OTC: ICNAF) Delic Holdings (CSE: DELC) (OTC: DELCF)...
Feb 23, 2021 04:00 pm ET
Organigram Holdings Inc. Announces Election of Directors
MONCTON, NB, Feb. 23, 2021 /CNW/ - Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual meeting of shareholders held on February 23, 2021 (the "Meeting").
Feb 09, 2021 09:30 am ET
CEO’s of OrganiGram, Icanic Brands, Red Light Holland, and Sundial Growers, Driving New Growth Opportunities in Cannabis and Psychedelics
Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: OrganiGram Holdings (NASDAQ: OGI), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Red Light Holland (OTC:...
Feb 02, 2021 09:00 am ET
Organigram Announces Executive Changes
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announces Matt Rogers, Senior Vice President, Operations, will be leaving Organigram at the end of May 2021 to pursue other interests.
Jan 13, 2021 07:12 am ET
Why Experts Believe 2021 is Anticipated to be a Strong Year For Cannabis Industry
PALM BEACH, Florida, Jan. 13, 2021 /PRNewswire/ -- January 13, 2021 - It's that time of the year when various articles and reports look back on the U.S. and Canadian 2020 cannabis markets' performance. Many agree that while both markets performed well in toto they say that the cannabis industry had a strong year with the U.S. markets significantly outperforming Canadian peers. The cannabis sector just finished a strong 2020 with the U.S. market soaring while many Canadian stocks struggled. An recent article said: "Looking into 2021, we think the theme will continue to play out as the world's
Jan 12, 2021 06:00 am ET
Organigram Reports First Quarter Fiscal 2021 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2020 (“Q1 Fiscal 2021” or “Q1 2021”).
Jan 11, 2021 06:00 am ET
Organigram Appoints Marni Wieshofer to the Board of Directors
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the appointment of Marni Wieshofer, to the Company’s Board of Directors. Ms. Wieshofer is Organigram’s first U.S. domiciled director and will assume her board position effective January 12, 2021.
Jan 04, 2021 06:00 am ET
Organigram to Report First Quarter Fiscal 2021 Results on January 12, 2021
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter Fiscal 2021 ended November 30, 2020 on Tuesday January 12, 2021 before market open.
Dec 22, 2020 06:00 am ET
Organigram Expands Edison Portfolio With Three New Indica Genetics – Black Cherry Punch, Ice Cream Cake (I.C.C.), and Slurricane
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of three new Edison Cannabis Co. (“Edison”) Indica strains including high potency Black Cherry Punch and Ice Cream Cake (I.C.C.) and full flavour Slurricane.
Dec 16, 2020 06:00 am ET
Organigram Launches New 1g Trailblazer Torch Vape Cartridges
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of Trailblazer Spark, Flicker and Glow 510-thread Torch vape cartridges in a new 1g format.
Nov 30, 2020 06:00 am ET
Organigram Reports Fourth Quarter 2020 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the fourth quarter ended August 31, 2020 (“Q4” or “Q4 2020”).
Nov 24, 2020 05:20 pm ET
Organigram to Report Fourth Quarter and Full Year Fiscal 2020 Results on November 30, 2020
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and full year Fiscal 2020 ended August 31, 2020 on Monday November 30th, 2020 before market open.
Nov 17, 2020 06:00 am ET
Organigram Launches Edison RE:MIX Rapid Dissolvable Cannabis Powder
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of Edison RE:MIX dissolvable cannabis powder. RE:MIX is the latest innovation from the Company’s Edison brand portfolio of products, offering Canadian adults the opportunity to enjoy cannabis their way.
Nov 12, 2020 09:13 am ET
Organigram Closes Previously Announced Underwritten Public Offering
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today the closing of its previously announced underwritten public offering of units of the Company (the “Units”) for total gross proceeds of C$69,143,750 (the “Offering”). The Company sold 37,375,000 Units at a price of C$1.85 per Unit, including 4,875,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.
Nov 10, 2020 06:09 am ET
Organigram Announces $60 Million Underwritten Public Offering
MONCTON, NB, Nov. 10, 2020 /CNW/ - Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today an underwritten public offering of units of the Company (the "Units") whereby a syndicate of underwriters, led by Canaccord Genuity Corp., has agreed to purchase 32,500,000 Units from the Company at a price of C$1.85 per Unit, for total gross proceeds of C$60,125,000 (the "Offering").
Nov 10, 2020 06:09 am ET
Organigram Announces $60 Million Underwritten Public Offering
MONCTON, NB, Nov. 10, 2020 /PRNewswire/ - Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today an underwritten public offering of units of the Company (the "Units") whereby a syndicate of underwriters, led by Canaccord Genuity Corp., has agreed to purchase 32,500,000 Units from the Company at a price of C$1.85 per Unit, for total gross proceeds of C$60,125,000 (the "Offering").
Nov 09, 2020 06:00 am ET
Organigram Launches Trailblazer Kushmas Stix and Edison Bytes Gingerbread Truffles -- Two New Limited-Edition Holiday Offerings
As winter and the holidays draw nearer, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of the Company’s limited-edition spirit-of-the-season offerings, Trailblazer Kushmas Stix and Edison Bytes Gingerbread Truffles.
Oct 30, 2020 06:00 am ET
Organigram CEO Joins Canadian Chamber of Commerce Board of Directors
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company’s Chief Executive Officer, Greg Engel, has accepted a position on the Board of Directors of the Canadian Chamber of Commerce.
Oct 23, 2020 06:00 am ET
Organigram Confirms Additional $2.5 Million Investment in Hyasynth Biologicals Inc. as Biosynthesis Pioneer Completes First Milestone Linked to First Sale of Commercial Product and Announces Executive
As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has funded an additional $2.5 million investment in Hyasynth Biologicals Inc. (“Hyasynth”), a private biotechnology company and pioneer in the field of cannabinoid science and biosynthesis. The announcement comes as Hyasynth makes the first sale of CBDa1 produced and extracted from yeast.
Sep 17, 2020 06:00 am ET
Organigram Expands Strong Value Portfolio With Launch of SHRED: High Quality, High Potency, Affordable Pre-shredded Dried Flower
In an effort to continue to break down the barriers to purchasing from the legal cannabis market in Canada, and reinforce its ongoing commitment to value, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of SHRED, a high quality, high potency, affordable dried flower product pre-shredded for additional consumer convenience.
Aug 18, 2020 06:00 am ET
Organigram Joins Medical Cannabis by Shoppers Inc. and TruTrace in Effort to Track Source and Genetics of Cannabis Used by Medical Patients
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has partnered with Medical Cannabis by Shoppers™ (“Shoppers”) on Phase 2 of Shoppers’ Pilot Program powered by software partner TruTrace Technologies Inc. (CSE: TTT; OTCQB: TTTSF) (“TruTrace”).
Aug 14, 2020 06:00 am ET
Organigram Sends First Shipment of Indoor-Grown Dried Flower to Israeli Cannabis Producer, Canndoc Ltd.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced that it has sent its first shipment of bulk dried flower to Canndoc Ltd. (“Canndoc”), one of Israel’s largest and most established medical cannabis producers, and a subsidiary of InterCure Ltd. (TASE: INCR). The shipment is part of Organigram’s multi-year deal with Canndoc and is estimated to be worth approximately $2.4M CDN.
Aug 04, 2020 06:00 am ET
Organigram Strengthens Edison Flower Portfolio with Three New High Potency Strains – The General (Grapefruit GG4), Chemdog and Samurai Spy (Ninja Fruit)
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of three new strains of Edison Cannabis Co. (“Edison”) dried flower products, including higher tetrahydrocannabinol (THC) options The General (Grapefruit GG4), Chemdog and limited time option Samurai Spy (Ninja Fruit).
Jul 28, 2020 06:00 am ET
Organigram Launches Trailblazer Snax, the Largest, Competitively Priced Cannabis-Infused Chocolate Bar in Canada
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of its most recent cannabis 2.0 product Trailblazer Snax, a premium-quality, value-priced, cannabis-infused chocolate bar.
Jul 21, 2020 06:00 am ET
Organigram Reports Third Quarter Fiscal 2020 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its results for the third quarter ended May 31, 2020 (“Q3” or “Q3 2020”).
Jul 20, 2020 07:00 pm ET
Organigram Announces Executive Change
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announces that Ray Gracewood, Senior Vice President of Marketing and Communications has left Organigram to pursue other interests.
Jul 03, 2020 08:00 am ET
Organigram Provides Update on COVID-19 Corporate Action Plan and Timing for Q3 Results
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) provides a corporate update on recent developments of the Company in relation to the worldwide COVID-19 pandemic and the continuing evolution of the Canadian cannabis industry.
Jun 23, 2020 06:00 am ET
Organigram Holdings Inc. Provides Corporate Updates
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announces a number of corporate updates.
Jun 09, 2020 08:45 am ET
Organigram and Canndoc Sign International Strategic Agreement
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced that it has entered into a multi-year agreement for supply of dried flower to one of Israel’s largest and most established medical cannabis producers, Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (TASE: INCR/INCR.TA).
May 29, 2020 06:00 am ET
Organigram Successfully Completes Amendment to Credit Facilities with Bank of Montreal
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (collectively, the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company has amended its credit agreement dated May 31, 2019, with Bank of Montreal (“BMO”) as lead arranger and agent as well as a syndicate including three other lenders (the “Credit Agreement Amendment”). The Credit Agreement Amendment modifies certain terms of the $115 million term loan (the “Term Loan”) and $25 million revolving credit facility (the “Revolver”, and together with the T
May 28, 2020 10:48 am ET
Organigram Rolls out Cannabis 2.0 Products to Medical Consumers
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that as of May 19th, 2020, the Company has extended its medical cannabis offering to include products from its cannabis 2.0 adult-use recreational portfolio.
May 14, 2020 06:00 am ET
Organigram announces first phase of return-to-work strategy
As it continues to monitor and assess the implications of the COVID-19 pandemic, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, has announced the first phase of its return-to-work strategy. The Company has begun to implement a staggered return-to-work plan effective May 13, 2020.
Apr 30, 2020 11:12 am ET
Court Significantly Reduces Scope of Class Action
The Nova Scotia Court of Appeal has partially overturned the certification of a class action (the “Class Action”) against Organigram Inc. (the "Company" or "Organigram") and its parent company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis in Canada, on April 30, 2020 thereby significantly reducing the scope of the claim against the Company.
Apr 23, 2020 06:00 am ET
Consumer Research Drives Enhancements to Organigram Adult Recreational Commercial Portfolio
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to provide an update related to the Company’s current and anticipated releases of new adult use recreational cannabis products.
Apr 22, 2020 08:00 am ET
Organigram Holdings Inc. Announces At-The-Market Equity Program
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX:OGI) (NASDAQ:OGI) announced today that it has established an at-the-market equity program (the “ATM Program”) that allows the Corporation to issue up to C$49,000,000 (or its U.S. dollar equivalent) of common shares (“Common Shares”) from treasury to the public from time to time, at the Corporation’s discretion. Any Common Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”), the NASDAQ Global Select Market (the “NASDAQ”) or any other marketplace on w
Apr 14, 2020 06:00 am ET
Organigram Reports Second Quarter Fiscal 2020 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its results for the second quarter ended February 29, 2020 (“Q2” or “Q2 2020”).
Apr 06, 2020 07:30 pm ET
Organigram Provides Update on Corporate Action Plan in Response to COVID-19 Pandemic
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced the temporary layoff of approximately 45 per cent of its workforce primarily to help boost COVID-19 containment efforts representing approximately 400 employees.
Mar 23, 2020 06:00 am ET
Organigram Receives Health Canada License Renewal and Expansion for Final Elements of Phase 5 and Provides COVID-19 Update
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company has received Health Canada’s approval for the licensing of the remainder of its Phase 5 expansion together with the renewal of its licenses for standard cultivation, standard processing and sale for medical purposes under the Cannabis Regulations. The renewed and expanded licenses are effective as of March 20, 2020.
Mar 10, 2020 06:00 am ET
Ideal Potency of Edible Products 5MGs of THC or Less, Organigram Consumer Research Survey Concludes
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, has released summary findings gathered in a research project designed to learn more about Canadians’ perceptions and attitudes around cannabis edible products.
Mar 04, 2020 06:00 am ET
Organigram Expands Leadership Team with the Appointment of Chief Strategy Officer and Newly Appointed Chief Financial Officer
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that effective today Paolo De Luca, the Company’s current Chief Financial Officer (“CFO”) has been appointed Chief Strategy Officer and Derrick West, currently on the Company’s Board of Directors, is joining the Company as its CFO.
Feb 25, 2020 06:30 pm ET
Organigram Holdings Inc. Announces Election of Directors
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced today that each of the eight nominees listed in its management information circular dated January 23, 2020 (the “Circular”) was elected as a director of Organigram at the Annual and Special Meeting of Shareholders (the “Meeting”) held on February 25, 2020. The vote was conducted by a show of hands. Detailed results of the votes cast by proxy are set out below:
Feb 20, 2020 07:00 am ET
Organigram Continues Cannabis 2.0 Roll Out, Releases Edison Vape Pens Powered by Feather, and Edison Bytes to Markets Across Canada
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to continue the roll out of its innovative portfolio of recreational adult use cannabis products including vape pens and cannabis-infused chocolate.
Jan 23, 2020 06:00 am ET
Edison La Strada Selected Favourite THC Flower in Canada
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce products from its premium adult recreational Edison Cannabis Co. brand have been awarded top honours in the consumer-driven Leafly Readers Choice Awards.
Jan 16, 2020 06:00 am ET
Organigram Secures Supply Agreement With Medical Cannabis by Shoppers
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has secured a supply agreement with Medical Cannabis by Shoppers, the online medical cannabis platform by Shoppers Drug Mart Inc. (“Shoppers”).
Jan 14, 2020 04:00 pm ET
Organigram Reports First Quarter Fiscal 2020 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its results for the first quarter ended November 30, 2019 (“Q1” or “Q1 2020”).
Jan 09, 2020 06:00 pm ET
Organigram Selected by Canada’s Top 100 Employers
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has been chosen as one of Atlantic Canada’s Top Employers.
Jan 03, 2020 07:00 pm ET
Organigram to Report First Quarter Fiscal 2020 Results on January 14th, 2020 and Operational Update
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2020 ended November 30, 2019 on Tuesday, January 14th after market close.
Dec 23, 2019 06:00 am ET
Organigram Trailblazer Torch Vape Cartridges Among First ‘Cannabis 2.0’ Products Company Distributes to Market
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the first of its ‘Cannabis 2.0’ products have been released, including Trailblazer Spark, Flicker and Glow 510-thread Torch vape cartridges.
Dec 13, 2019 06:00 am ET
Organigram Receives Licensing for Chocolate Production and Packaging Area; Increased Production, Drying and Other Post-Harvesting Areas
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company has received Health Canada’s approval for the licensing of 16 additional cultivation rooms under the Cannabis Regulations. The expanded license was effective as of December 12, 2019.
Dec 04, 2019 08:50 am ET
Organigram Holdings Inc. Announces At-The-Market Equity Program
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced today that it has established an at-the-market equity program (the “ATM Program”) that allows the Corporation to issue up to C$55,000,000 (or its U.S. dollar equivalent) of common shares (“Common Shares”) from treasury to the public from time to time, at the Corporation’s discretion. Any Common Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”), the NASDAQ Global Select Market (the “NASDAQ”) or any other marketplace on
Nov 25, 2019 06:00 am ET
Organigram Reports Fourth Quarter and 2019 Fiscal Year Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its results for the fourth quarter and fiscal year ended August 31, 2019 (“Q4” or “Q4 2019”).
Nov 11, 2019 06:30 pm ET
Organigram Provides Corporate Update
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, provided a corporate update today and announced details for its fiscal fourth quarter ended August 31, 2019 (“Q4 2019”) and full year 2019 conference call. The Company is scheduled to report its fourth quarter and full year earnings results for its fiscal year ended August 31, 2019 on Monday, November 25, 2019 before market open.
Nov 11, 2019 06:00 am ET
Organigram Wins Top Product Award in High THC Bottled Oil Category at 2019 Canadian Cannabis Awards
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company was honoured on November 8 at the Canadian Cannabis Awards Gala in Toronto with the Top Product Award in the High THC Bottled Oil Category for its medical product, Rossignol. The annual ceremony honours outstanding people, products and companies in Canadian cannabis.
Oct 10, 2019 06:00 am ET
Organigram Awarded Excellence in Manufacturing Consortium Award
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company was recognized at the Excellence in Manufacturing Consortium (“EMC”) Awards of Excellence ceremony in Toronto on October 9.
Oct 07, 2019 06:00 am ET
Organigram Assumes Board Positions on International Cannabis Industry Advocacy Organizations
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that a representative of the Company has assumed board positions with three international organizations committed to promote and foster global cannabis industry growth: The American Trade Association for Cannabis and Hemp, The Policy Center for Public Health & Safety (both U.S.-based) and the European Alliance for Medical Cannabis.
Oct 03, 2019 08:30 am ET
Organigram Holdings Inc. CEO Discusses Rampant Growth in Exclusive NetworkNewsWire Broadcast
via NetworkNewsAudio – Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI), parent company of Organigram Inc., today announces the broadcast of its audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients...
Sep 26, 2019 06:00 am ET
BTV Uncovers Companies in the Growing Cannabis Sector
Vancouver, British Columbia--(Newsfile Corp. - September 26, 2019) - On national TV Sat. Sept. 28 & Sun. Sept. 29, 2019 - As the Canadian cannabis sector remains strong, BTV- Business Television visits thriving opportunities ripe for investment.
Sep 09, 2019 06:00 am ET
Organigram Receives Health Canada Approval to Bring Total Licensed Production Capacity to Target of 76,000 kg/yr1
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that effective September 6, 2019 it has received Health Canada’s approval for the licensing of 17 additional cultivation rooms under the Cannabis Regulations.
Aug 20, 2019 06:00 am ET
Organigram Announces Trading Date for Graduation to TSX
Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that it has received final approval for the listing of its common shares on the Toronto Stock Exchange (“TSX”).
Aug 08, 2019 08:00 pm ET
Organigram Conditionally Approved to Graduate to the TSX
Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has received conditional approval from the Toronto Stock Exchange (“TSX”) to graduate from the TSX Venture Exchange (“TSXV”) and list its common shares on the TSX under the symbol “OGI.”
Jul 26, 2019 08:15 am ET
Organigram Signs New Agreement for Access to 60,000kg of CBD-rich Hemp
Organigram Holdings Inc. (NASDAQ Global Select; TSX-V: OGI) the parent company of Organigram Inc. (collectively the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that it has entered into an advance payment and purchase agreement (the “Payment Agreement”) with 703454 N.B. Inc. (carrying on business as 1812 Hemp) (“1812 Hemp”) under which the Company will pre-fund hemp purchases to receive access to as much as 60,000 kilograms of dried hemp flower to be harvested in calendar 2019 for extraction into cannabidiol (“CBD”) isolate.
Jul 15, 2019 06:00 am ET
Organigram Reports Third Quarter Fiscal 2019 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its results for the third quarter ended May 31, 2019 (“Q3” or “Q3 2019”).
Jul 12, 2019 10:40 am ET
Company Profile for Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park
Jul 10, 2019 06:01 am ET
Organigram and Lift & Co. Enhance Education of Cannabis Frontline Staff via Brand-Specific Training Program
Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce a collaboration with Lift & Co. Corp ("Lift & Co.") (TSXV: LIFT) (OTCQB: LFCOF) to support the launch of Canada’s first branded cannabis educational program via Lift & Co.’s CannSell retail training program.
Jul 08, 2019 04:00 pm ET
Organigram Announces Expanded Development of Rapid-Onset Nano-Emulsification Technology for Cannabis Beverages
In anticipation of the legalization of adult use recreational cannabis edibles in Canada, as well as consumer demand for cannabis-infused beverages, Organigram Holdings Inc. (TSX VENTURE: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, has developed a proprietary nano-emulsification technology that will allow for the production of both liquid and powdered cannabinoid products.
Jul 02, 2019 06:00 am ET
Organigram Holdings Inc. to Report Third Quarter Fiscal 2019 Results on July 15, 2019
MONCTON, NB, July 2, 2019 /CNW/ - Organigram Holdings Inc. (NASDAQ: OGI) (TSXV: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report its third quarter earnings results for its fiscal year ended August 31, 2019 on Monday, July 15, 2019 before market open.
Jul 02, 2019 06:00 am ET
Organigram Holdings Inc. to Report Third Quarter Fiscal 2019 Results on July 15, 2019
MONCTON, NB, July 2, 2019 /PRNewswire/ - Organigram Holdings Inc. (NASDAQ: OGI) (TSXV: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report its third quarter earnings results for its fiscal year ended August 31, 2019 on Monday, July 15, 2019 before market open.
Jun 24, 2019 06:00 am ET
Organigram Receives Health Canada Approval for an Additional 17 Cultivation Rooms in Phase 4A
Additional licensed cultivation space brings annual target production capacity to 61,000 kg/yr1
Jun 20, 2019 06:00 am ET
Organigram sends first shipment to Quebec; Organigram products now available in all ten provinces
MONCTON, NB, June 20, 2019 /CNW/ - Organigram Holdings Inc. (TSXV: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that it has now shipped its first cannabis products to the province of Quebec, following purchase orders placed with the Société québécoise du cannabis (SQDC) and following registration with the Autorité des Marchés Publics.
Jun 18, 2019 06:00 am ET
Organigram becomes exclusive Canadian supplier of Feather Company's design-patented vaporizer hardware and technology
Agreement pairs innovative Edison brand with unique, proprietary delivery mechanism for discerning & sophisticated consumers
Jun 07, 2019 09:15 am ET
Organigram Secures Partnership with PAX as Brand Partner
Partnership with PAX builds on Organigram's commitment to both quality and a strong leadership position with next generation cannabis products Organigram plans to offer Edison Cannabis Co. brand PAX Era pods coast to coast, through the Company's distribution arrangements in all of Canada's ten provinces Estimates suggest vape pens currently represent the largest segment of edibles and derivative based products at approximately 23 per cent of U.S. sales based on form factori
May 31, 2019 03:05 pm ET
Organigram Closes $140 Million Credit Facility with Bank of Montreal
Non-dilutive Financing Provides Company with Significant Financial Flexibility
May 31, 2019 06:00 am ET
Organigram Receives Organic Certification for Recreational Cannabis
MONCTON, NB, May 31, 2019 /CNW/ – Organigram Holdings Inc. (TSXV: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce its recreational cannabis plants and growing processes have been certified organic with Pro-Cert Organic Systems Ltd. ("Pro-Cert").
May 29, 2019 06:00 am ET
Organigram fulfills gap in Canadian CBD Market with Edison CBD Oil
Company sends initial shipments of more than 130 thousand units
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
